Alkermes Plc (ALKS)
29.20
-1.05
(-3.47%)
USD |
NASDAQ |
Mar 03, 16:00
29.20
0.00 (0.00%)
After-Hours: 20:00
Alkermes Research and Development Expense (Annual) : 318.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Avadel Pharmaceuticals Plc | 15.20M |
| Krystal Biotech, Inc. | 52.32M |
| Assertio Holdings, Inc. | 3.822M |
| Amarin Corp. Plc | 19.85M |
| Amicus Therapeutics, Inc. | 135.84M |